{"id":20105,"date":"2026-10-08T09:41:45","date_gmt":"2026-10-08T09:41:45","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/?post_type=case-study&p=20105"},"modified":"2026-10-08T10:28:58","modified_gmt":"2026-10-08T10:28:58","slug":"rethinking-e-coli-expression-how-clearcoli-is-simplifying-cost-effective-low-endotoxin-protein-production-at-sygnature-discovery","status":"publish","type":"case-study","link":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/rethinking-e-coli-expression-how-clearcoli-is-simplifying-cost-effective-low-endotoxin-protein-production-at-sygnature-discovery\/","title":{"rendered":"Rethinking E. coli Expression: How ClearColi\u2122 is Simplifying Cost Effective, Low-Endotoxin Protein Production at Sygnature Discovery"},"content":{"rendered":"\n

The challenge of endotoxin contamination is one of the most persistent hurdles in recombinant protein production. For researchers working with proteins destined for cell-based assays, immunology studies, or other endotoxin-sensitive applications, removing bacterial endotoxins can add complexity, cost, and risk to downstream workflows. Now, cell scientists at Sygnature Discovery\u2019s Protein & Structure departments in both the UK and Canada have a powerful new tool to tackle this challenge at its source: ClearColi\u2122 Expression Technology<\/strong>.<\/h2>\n\n\n\n

Eliminating Endotoxins Before They Become a Problem<\/strong><\/h3>\n\n\n\n

For several decades, E. coli<\/em> has been one of the workhorses of recombinant protein expression. It is fast-growing, cost-effective, and genetically well understood. However, there is a catch. Like all Gram-negative bacteria, E. coli<\/em> naturally produces lipopolysaccharide (LPS), commonly known as endotoxin<\/strong>.<\/p>\n\n\n\n

While endotoxins are essential for bacterial survival, they can pose significant problems in research and therapeutic development. Even trace amounts can trigger inflammatory responses in mammalian cells, complicating experimental results and requiring extensive downstream purification efforts.<\/p>\n\n\n\n

At Sygnature Discovery, we are pleased to announce the availability of ClearColi\u2122 Expression Technology<\/strong> (licensed from Research Corporation Technologies, Tuscon, Arizona, USA), providing our clients with a low-endotoxin solution for recombinant protein expression in E. coli<\/em>.<\/p>\n\n\n\n

What Exactly Are Endotoxins?<\/strong><\/h3>\n\n\n\n

Endotoxins are structural components found in the outer membrane of Gram-negative bacteria. Their primary role is to protect bacterial cells from environmental stress and maintain membrane integrity.<\/p>\n\n\n\n

Unlike many biological membranes, the outer membrane of E. coli<\/em> is not composed solely of phospholipids. Instead, its outer surface is rich in LPS molecules, which form a protective barrier between the bacterium and its environment (Figure 1).<\/p>\n\n\n\n

\"Endotoxin
Figure 1: <\/strong>Cartoon schematic of the outer\/inner membrane of an E. coli cell. Gram-negative bacteria, such as E. coli are characterised by two membranes: the inner and the outer membrane. The latter separates the bacterial cell wall from the external environment and includes LPS or endotoxins.<\/figcaption><\/figure>\n\n\n\n

Although beneficial for bacteria, LPS is highly recognizable to the mammalian immune system. When introduced into animal or human cells, endotoxins can activate powerful inflammatory pathways, potentially leading to immune activation, endotoxic shock, or sepsis at high concentrations.<\/p>\n\n\n\n

For scientists working with purified proteins, controlling endotoxin contamination is therefore critical. Many downstream applications, particularly cell-based studies, require extremely low endotoxin levels to ensure reliable data.<\/p>\n\n\n\n

Why Traditional Endotoxin Removal Isn\u2019t Always Enough<\/strong><\/h3>\n\n\n\n

Protein scientists are familiar with the ongoing battle against endotoxin contamination.<\/p>\n\n\n\n

Common strategies to combat this include:<\/p>\n\n\n\n